nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—PTGER4—multiple sclerosis	0.455	1	CbGaD
Dinoprostone—SLCO3A1—Methotrexate—multiple sclerosis	0.0476	0.132	CbGbCtD
Dinoprostone—CYP11A1—Dexamethasone—multiple sclerosis	0.0359	0.099	CbGbCtD
Dinoprostone—SLC22A2—Cladribine—multiple sclerosis	0.0351	0.0968	CbGbCtD
Dinoprostone—SLC22A1—Cladribine—multiple sclerosis	0.0305	0.0841	CbGbCtD
Dinoprostone—SLCO1C1—Methotrexate—multiple sclerosis	0.0304	0.084	CbGbCtD
Dinoprostone—CYP19A1—Betamethasone—multiple sclerosis	0.0287	0.0792	CbGbCtD
Dinoprostone—SLCO1A2—Prednisolone—multiple sclerosis	0.0222	0.0612	CbGbCtD
Dinoprostone—SLCO1A2—Prednisone—multiple sclerosis	0.0209	0.0577	CbGbCtD
Dinoprostone—CYP19A1—Dexamethasone—multiple sclerosis	0.0167	0.0461	CbGbCtD
Dinoprostone—SLC22A11—Methotrexate—multiple sclerosis	0.0157	0.0434	CbGbCtD
Dinoprostone—SLC22A7—Methotrexate—multiple sclerosis	0.015	0.0413	CbGbCtD
Dinoprostone—ABCC4—Methotrexate—multiple sclerosis	0.0146	0.0404	CbGbCtD
Dinoprostone—SLCO1A2—Dexamethasone—multiple sclerosis	0.0131	0.0361	CbGbCtD
Dinoprostone—SLCO1A2—Methotrexate—multiple sclerosis	0.0105	0.029	CbGbCtD
Dinoprostone—SLCO1B1—Methotrexate—multiple sclerosis	0.0099	0.0273	CbGbCtD
Dinoprostone—SLC22A8—Methotrexate—multiple sclerosis	0.00914	0.0252	CbGbCtD
Dinoprostone—SLC22A6—Methotrexate—multiple sclerosis	0.00637	0.0176	CbGbCtD
Dinoprostone—Misoprostol—PTGER4—multiple sclerosis	0.0034	1	CrCbGaD
Dinoprostone—HPGDS—brainstem—multiple sclerosis	0.000941	0.0291	CbGeAlD
Dinoprostone—PTGIR—brainstem—multiple sclerosis	0.000767	0.0237	CbGeAlD
Dinoprostone—PTGER4—nervous system—multiple sclerosis	0.000674	0.0209	CbGeAlD
Dinoprostone—SLC51A—nervous system—multiple sclerosis	0.000662	0.0205	CbGeAlD
Dinoprostone—HPGDS—medulla oblongata—multiple sclerosis	0.000656	0.0203	CbGeAlD
Dinoprostone—SLCO3A1—retina—multiple sclerosis	0.000653	0.0202	CbGeAlD
Dinoprostone—PTGER1—nervous system—multiple sclerosis	0.000651	0.0201	CbGeAlD
Dinoprostone—PTGER4—central nervous system—multiple sclerosis	0.000649	0.0201	CbGeAlD
Dinoprostone—SLC51A—central nervous system—multiple sclerosis	0.000637	0.0197	CbGeAlD
Dinoprostone—PTGER1—central nervous system—multiple sclerosis	0.000626	0.0194	CbGeAlD
Dinoprostone—HPGDS—midbrain—multiple sclerosis	0.0006	0.0186	CbGeAlD
Dinoprostone—SLCO4A1—retina—multiple sclerosis	0.000595	0.0184	CbGeAlD
Dinoprostone—ABCC5—retina—multiple sclerosis	0.000592	0.0183	CbGeAlD
Dinoprostone—HPGDS—spinal cord—multiple sclerosis	0.000585	0.0181	CbGeAlD
Dinoprostone—PTGER3—nervous system—multiple sclerosis	0.000571	0.0177	CbGeAlD
Dinoprostone—PTGER3—central nervous system—multiple sclerosis	0.000549	0.017	CbGeAlD
Dinoprostone—PTGER4—brain—multiple sclerosis	0.000515	0.0159	CbGeAlD
Dinoprostone—SLC51A—brain—multiple sclerosis	0.000506	0.0157	CbGeAlD
Dinoprostone—HPGDS—nervous system—multiple sclerosis	0.000493	0.0153	CbGeAlD
Dinoprostone—SLCO1C1—midbrain—multiple sclerosis	0.000491	0.0152	CbGeAlD
Dinoprostone—SLCO1C1—spinal cord—multiple sclerosis	0.000479	0.0148	CbGeAlD
Dinoprostone—PTGIR—spinal cord—multiple sclerosis	0.000477	0.0148	CbGeAlD
Dinoprostone—HPGDS—central nervous system—multiple sclerosis	0.000475	0.0147	CbGeAlD
Dinoprostone—SLCO3A1—medulla oblongata—multiple sclerosis	0.000472	0.0146	CbGeAlD
Dinoprostone—CYP11A1—medulla oblongata—multiple sclerosis	0.000463	0.0143	CbGeAlD
Dinoprostone—PTGER3—brain—multiple sclerosis	0.000436	0.0135	CbGeAlD
Dinoprostone—SLCO3A1—midbrain—multiple sclerosis	0.000432	0.0134	CbGeAlD
Dinoprostone—SLCO4A1—medulla oblongata—multiple sclerosis	0.00043	0.0133	CbGeAlD
Dinoprostone—ABCC5—medulla oblongata—multiple sclerosis	0.000428	0.0132	CbGeAlD
Dinoprostone—SLCO3A1—spinal cord—multiple sclerosis	0.000421	0.013	CbGeAlD
Dinoprostone—SLCO1C1—nervous system—multiple sclerosis	0.000403	0.0125	CbGeAlD
Dinoprostone—PTGIR—nervous system—multiple sclerosis	0.000402	0.0124	CbGeAlD
Dinoprostone—SLCO4A1—midbrain—multiple sclerosis	0.000393	0.0122	CbGeAlD
Dinoprostone—ABCC5—midbrain—multiple sclerosis	0.000391	0.0121	CbGeAlD
Dinoprostone—SLCO1C1—central nervous system—multiple sclerosis	0.000388	0.012	CbGeAlD
Dinoprostone—PTGIR—central nervous system—multiple sclerosis	0.000387	0.012	CbGeAlD
Dinoprostone—SLCO4A1—spinal cord—multiple sclerosis	0.000384	0.0119	CbGeAlD
Dinoprostone—PTGIR—cerebellum—multiple sclerosis	0.000378	0.0117	CbGeAlD
Dinoprostone—HPGDS—brain—multiple sclerosis	0.000377	0.0117	CbGeAlD
Dinoprostone—SLCO3A1—nervous system—multiple sclerosis	0.000355	0.011	CbGeAlD
Dinoprostone—SLCO2A1—nervous system—multiple sclerosis	0.000351	0.0109	CbGeAlD
Dinoprostone—CYP11A1—nervous system—multiple sclerosis	0.000348	0.0108	CbGeAlD
Dinoprostone—SLCO3A1—central nervous system—multiple sclerosis	0.000342	0.0106	CbGeAlD
Dinoprostone—SLCO2A1—central nervous system—multiple sclerosis	0.000338	0.0105	CbGeAlD
Dinoprostone—SLCO2B1—medulla oblongata—multiple sclerosis	0.000335	0.0104	CbGeAlD
Dinoprostone—CYP11A1—central nervous system—multiple sclerosis	0.000335	0.0104	CbGeAlD
Dinoprostone—SLCO3A1—cerebellum—multiple sclerosis	0.000334	0.0103	CbGeAlD
Dinoprostone—SLCO4A1—nervous system—multiple sclerosis	0.000323	0.01	CbGeAlD
Dinoprostone—SLCO4A1—central nervous system—multiple sclerosis	0.000311	0.00963	CbGeAlD
Dinoprostone—SLCO1C1—brain—multiple sclerosis	0.000308	0.00954	CbGeAlD
Dinoprostone—SLCO1A2—medulla oblongata—multiple sclerosis	0.000308	0.00953	CbGeAlD
Dinoprostone—PTGIR—brain—multiple sclerosis	0.000307	0.00951	CbGeAlD
Dinoprostone—SLCO4A1—cerebellum—multiple sclerosis	0.000304	0.00941	CbGeAlD
Dinoprostone—ABCC5—cerebellum—multiple sclerosis	0.000302	0.00936	CbGeAlD
Dinoprostone—SLCO2B1—spinal cord—multiple sclerosis	0.000298	0.00924	CbGeAlD
Dinoprostone—SLC22A7—brain—multiple sclerosis	0.000292	0.00905	CbGeAlD
Dinoprostone—SLC22A6—brain—multiple sclerosis	0.000282	0.00873	CbGeAlD
Dinoprostone—SLCO1A2—midbrain—multiple sclerosis	0.000282	0.00871	CbGeAlD
Dinoprostone—SLCO1A2—spinal cord—multiple sclerosis	0.000275	0.0085	CbGeAlD
Dinoprostone—SLCO3A1—brain—multiple sclerosis	0.000271	0.00839	CbGeAlD
Dinoprostone—SLCO2A1—brain—multiple sclerosis	0.000269	0.00831	CbGeAlD
Dinoprostone—CYP11A1—brain—multiple sclerosis	0.000266	0.00822	CbGeAlD
Dinoprostone—SLCO2B1—nervous system—multiple sclerosis	0.000252	0.00778	CbGeAlD
Dinoprostone—SLCO4A1—brain—multiple sclerosis	0.000247	0.00765	CbGeAlD
Dinoprostone—ABCC5—brain—multiple sclerosis	0.000246	0.0076	CbGeAlD
Dinoprostone—SLCO2B1—central nervous system—multiple sclerosis	0.000242	0.00749	CbGeAlD
Dinoprostone—SLC22A1—nervous system—multiple sclerosis	0.00024	0.00744	CbGeAlD
Dinoprostone—SLCO2B1—cerebellum—multiple sclerosis	0.000237	0.00733	CbGeAlD
Dinoprostone—SLCO1A2—nervous system—multiple sclerosis	0.000231	0.00716	CbGeAlD
Dinoprostone—SLC22A1—central nervous system—multiple sclerosis	0.000231	0.00716	CbGeAlD
Dinoprostone—CYP19A1—nervous system—multiple sclerosis	0.000226	0.00699	CbGeAlD
Dinoprostone—SLCO1A2—central nervous system—multiple sclerosis	0.000223	0.0069	CbGeAlD
Dinoprostone—ABCC4—nervous system—multiple sclerosis	0.000223	0.00689	CbGeAlD
Dinoprostone—SLC22A8—nervous system—multiple sclerosis	0.000221	0.00684	CbGeAlD
Dinoprostone—SLCO1A2—cerebellum—multiple sclerosis	0.000218	0.00674	CbGeAlD
Dinoprostone—CYP19A1—central nervous system—multiple sclerosis	0.000217	0.00673	CbGeAlD
Dinoprostone—ABCC4—central nervous system—multiple sclerosis	0.000214	0.00664	CbGeAlD
Dinoprostone—SLC22A8—central nervous system—multiple sclerosis	0.000213	0.00659	CbGeAlD
Dinoprostone—SLCO2B1—brain—multiple sclerosis	0.000192	0.00595	CbGeAlD
Dinoprostone—Arthralgia—Azathioprine—multiple sclerosis	0.000187	0.00352	CcSEcCtD
Dinoprostone—Myalgia—Azathioprine—multiple sclerosis	0.000187	0.00352	CcSEcCtD
Dinoprostone—Sweating increased—Methylprednisolone—multiple sclerosis	0.000187	0.00352	CcSEcCtD
Dinoprostone—SLC22A1—brain—multiple sclerosis	0.000184	0.00569	CbGeAlD
Dinoprostone—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000184	0.00346	CcSEcCtD
Dinoprostone—Chills—Mitoxantrone—multiple sclerosis	0.000183	0.00345	CcSEcCtD
Dinoprostone—Myocardial infarction—Prednisolone—multiple sclerosis	0.000183	0.00344	CcSEcCtD
Dinoprostone—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000182	0.00343	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00018	0.0034	CcSEcCtD
Dinoprostone—SLCO1A2—brain—multiple sclerosis	0.000177	0.00548	CbGeAlD
Dinoprostone—Body temperature increased—Cladribine—multiple sclerosis	0.000174	0.00328	CcSEcCtD
Dinoprostone—Abdominal pain—Cladribine—multiple sclerosis	0.000174	0.00328	CcSEcCtD
Dinoprostone—CYP19A1—brain—multiple sclerosis	0.000173	0.00534	CbGeAlD
Dinoprostone—Back pain—Mitoxantrone—multiple sclerosis	0.000172	0.00324	CcSEcCtD
Dinoprostone—ABCC4—brain—multiple sclerosis	0.00017	0.00527	CbGeAlD
Dinoprostone—Sweating increased—Dexamethasone—multiple sclerosis	0.00017	0.0032	CcSEcCtD
Dinoprostone—Sweating increased—Betamethasone—multiple sclerosis	0.00017	0.0032	CcSEcCtD
Dinoprostone—SLC22A8—brain—multiple sclerosis	0.000169	0.00523	CbGeAlD
Dinoprostone—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000169	0.00319	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000168	0.00318	CcSEcCtD
Dinoprostone—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000168	0.00317	CcSEcCtD
Dinoprostone—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000167	0.00316	CcSEcCtD
Dinoprostone—Hypotension—Azathioprine—multiple sclerosis	0.000167	0.00316	CcSEcCtD
Dinoprostone—Vision blurred—Mitoxantrone—multiple sclerosis	0.000167	0.00315	CcSEcCtD
Dinoprostone—Cardiac arrest—Prednisone—multiple sclerosis	0.000167	0.00315	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000163	0.00308	CcSEcCtD
Dinoprostone—Hypersensitivity—Cladribine—multiple sclerosis	0.000162	0.00306	CcSEcCtD
Dinoprostone—Asthenia—Cladribine—multiple sclerosis	0.000158	0.00298	CcSEcCtD
Dinoprostone—Cough—Mitoxantrone—multiple sclerosis	0.000155	0.00292	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000153	0.00289	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000153	0.00289	CcSEcCtD
Dinoprostone—Hypertension—Mitoxantrone—multiple sclerosis	0.000153	0.00289	CcSEcCtD
Dinoprostone—Pharyngitis—Triamcinolone—multiple sclerosis	0.000153	0.00288	CcSEcCtD
Dinoprostone—Myocardial infarction—Betamethasone—multiple sclerosis	0.000152	0.00287	CcSEcCtD
Dinoprostone—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000152	0.00287	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000152	0.00286	CcSEcCtD
Dinoprostone—Arthralgia—Mitoxantrone—multiple sclerosis	0.000151	0.00285	CcSEcCtD
Dinoprostone—Myalgia—Mitoxantrone—multiple sclerosis	0.000151	0.00285	CcSEcCtD
Dinoprostone—Chest pain—Mitoxantrone—multiple sclerosis	0.000151	0.00285	CcSEcCtD
Dinoprostone—Diarrhoea—Cladribine—multiple sclerosis	0.000151	0.00284	CcSEcCtD
Dinoprostone—Arrhythmia—Prednisolone—multiple sclerosis	0.000149	0.00282	CcSEcCtD
Dinoprostone—Sweating increased—Prednisone—multiple sclerosis	0.000148	0.00279	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000146	0.00276	CcSEcCtD
Dinoprostone—Dizziness—Cladribine—multiple sclerosis	0.000146	0.00275	CcSEcCtD
Dinoprostone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000145	0.00273	CcSEcCtD
Dinoprostone—Shock—Mitoxantrone—multiple sclerosis	0.000142	0.00269	CcSEcCtD
Dinoprostone—Body temperature increased—Azathioprine—multiple sclerosis	0.000142	0.00267	CcSEcCtD
Dinoprostone—Abdominal pain—Azathioprine—multiple sclerosis	0.000142	0.00267	CcSEcCtD
Dinoprostone—Tachycardia—Mitoxantrone—multiple sclerosis	0.000141	0.00267	CcSEcCtD
Dinoprostone—Vomiting—Cladribine—multiple sclerosis	0.00014	0.00264	CcSEcCtD
Dinoprostone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00014	0.00264	CcSEcCtD
Dinoprostone—Angiopathy—Methylprednisolone—multiple sclerosis	0.000139	0.00263	CcSEcCtD
Dinoprostone—Rash—Cladribine—multiple sclerosis	0.000139	0.00262	CcSEcCtD
Dinoprostone—Dermatitis—Cladribine—multiple sclerosis	0.000139	0.00262	CcSEcCtD
Dinoprostone—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000139	0.00261	CcSEcCtD
Dinoprostone—Headache—Cladribine—multiple sclerosis	0.000138	0.0026	CcSEcCtD
Dinoprostone—Arrhythmia—Triamcinolone—multiple sclerosis	0.000137	0.00259	CcSEcCtD
Dinoprostone—Vision blurred—Prednisolone—multiple sclerosis	0.000137	0.00259	CcSEcCtD
Dinoprostone—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000137	0.00259	CcSEcCtD
Dinoprostone—Hypotension—Mitoxantrone—multiple sclerosis	0.000135	0.00255	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000133	0.00252	CcSEcCtD
Dinoprostone—Myocardial infarction—Prednisone—multiple sclerosis	0.000133	0.0025	CcSEcCtD
Dinoprostone—Hypersensitivity—Azathioprine—multiple sclerosis	0.000132	0.00249	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000132	0.00249	CcSEcCtD
Dinoprostone—Nausea—Cladribine—multiple sclerosis	0.000131	0.00247	CcSEcCtD
Dinoprostone—Syncope—Prednisolone—multiple sclerosis	0.00013	0.00246	CcSEcCtD
Dinoprostone—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00013	0.00245	CcSEcCtD
Dinoprostone—Back pain—Triamcinolone—multiple sclerosis	0.000129	0.00244	CcSEcCtD
Dinoprostone—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000129	0.00244	CcSEcCtD
Dinoprostone—Loss of consciousness—Prednisolone—multiple sclerosis	0.000128	0.00241	CcSEcCtD
Dinoprostone—Asthma—Methotrexate—multiple sclerosis	0.000127	0.00239	CcSEcCtD
Dinoprostone—Angiopathy—Dexamethasone—multiple sclerosis	0.000127	0.00239	CcSEcCtD
Dinoprostone—Angiopathy—Betamethasone—multiple sclerosis	0.000127	0.00239	CcSEcCtD
Dinoprostone—Hypertension—Prednisolone—multiple sclerosis	0.000126	0.00237	CcSEcCtD
Dinoprostone—Arrhythmia—Dexamethasone—multiple sclerosis	0.000125	0.00235	CcSEcCtD
Dinoprostone—Arrhythmia—Betamethasone—multiple sclerosis	0.000125	0.00235	CcSEcCtD
Dinoprostone—Pain—Mitoxantrone—multiple sclerosis	0.000124	0.00234	CcSEcCtD
Dinoprostone—Diarrhoea—Azathioprine—multiple sclerosis	0.000123	0.00231	CcSEcCtD
Dinoprostone—Syncope—Triamcinolone—multiple sclerosis	0.00012	0.00226	CcSEcCtD
Dinoprostone—Syncope—Methylprednisolone—multiple sclerosis	0.00012	0.00226	CcSEcCtD
Dinoprostone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000119	0.00224	CcSEcCtD
Dinoprostone—Dizziness—Azathioprine—multiple sclerosis	0.000118	0.00223	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000118	0.00223	CcSEcCtD
Dinoprostone—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000118	0.00222	CcSEcCtD
Dinoprostone—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000117	0.00221	CcSEcCtD
Dinoprostone—Shock—Prednisolone—multiple sclerosis	0.000117	0.0022	CcSEcCtD
Dinoprostone—Cough—Triamcinolone—multiple sclerosis	0.000117	0.0022	CcSEcCtD
Dinoprostone—Tachycardia—Prednisolone—multiple sclerosis	0.000116	0.00219	CcSEcCtD
Dinoprostone—Hypertension—Triamcinolone—multiple sclerosis	0.000116	0.00218	CcSEcCtD
Dinoprostone—Hypertension—Methylprednisolone—multiple sclerosis	0.000115	0.00218	CcSEcCtD
Dinoprostone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000115	0.00217	CcSEcCtD
Dinoprostone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000114	0.00216	CcSEcCtD
Dinoprostone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000114	0.00216	CcSEcCtD
Dinoprostone—Myalgia—Triamcinolone—multiple sclerosis	0.000114	0.00215	CcSEcCtD
Dinoprostone—Vomiting—Azathioprine—multiple sclerosis	0.000114	0.00215	CcSEcCtD
Dinoprostone—Myalgia—Methylprednisolone—multiple sclerosis	0.000114	0.00214	CcSEcCtD
Dinoprostone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000114	0.00214	CcSEcCtD
Dinoprostone—Rash—Azathioprine—multiple sclerosis	0.000113	0.00213	CcSEcCtD
Dinoprostone—Dermatitis—Azathioprine—multiple sclerosis	0.000113	0.00213	CcSEcCtD
Dinoprostone—Flushing—Prednisone—multiple sclerosis	0.000113	0.00213	CcSEcCtD
Dinoprostone—Headache—Azathioprine—multiple sclerosis	0.000112	0.00212	CcSEcCtD
Dinoprostone—Angiopathy—Prednisone—multiple sclerosis	0.00011	0.00208	CcSEcCtD
Dinoprostone—Immune system disorder—Prednisone—multiple sclerosis	0.00011	0.00207	CcSEcCtD
Dinoprostone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000109	0.00206	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000109	0.00206	CcSEcCtD
Dinoprostone—Syncope—Betamethasone—multiple sclerosis	0.000109	0.00205	CcSEcCtD
Dinoprostone—Syncope—Dexamethasone—multiple sclerosis	0.000109	0.00205	CcSEcCtD
Dinoprostone—Arrhythmia—Prednisone—multiple sclerosis	0.000108	0.00205	CcSEcCtD
Dinoprostone—Shock—Triamcinolone—multiple sclerosis	0.000107	0.00203	CcSEcCtD
Dinoprostone—Shock—Methylprednisolone—multiple sclerosis	0.000107	0.00202	CcSEcCtD
Dinoprostone—Loss of consciousness—Betamethasone—multiple sclerosis	0.000107	0.00201	CcSEcCtD
Dinoprostone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000107	0.00201	CcSEcCtD
Dinoprostone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000107	0.00201	CcSEcCtD
Dinoprostone—Paraesthesia—Prednisolone—multiple sclerosis	0.000107	0.00201	CcSEcCtD
Dinoprostone—Tachycardia—Triamcinolone—multiple sclerosis	0.000107	0.00201	CcSEcCtD
Dinoprostone—Nausea—Azathioprine—multiple sclerosis	0.000106	0.00201	CcSEcCtD
Dinoprostone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000106	0.00201	CcSEcCtD
Dinoprostone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000106	0.00199	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000105	0.00199	CcSEcCtD
Dinoprostone—Hypertension—Betamethasone—multiple sclerosis	0.000105	0.00198	CcSEcCtD
Dinoprostone—Hypertension—Dexamethasone—multiple sclerosis	0.000105	0.00198	CcSEcCtD
Dinoprostone—Asthenia—Mitoxantrone—multiple sclerosis	0.000104	0.00196	CcSEcCtD
Dinoprostone—Myalgia—Betamethasone—multiple sclerosis	0.000103	0.00195	CcSEcCtD
Dinoprostone—Myalgia—Dexamethasone—multiple sclerosis	0.000103	0.00195	CcSEcCtD
Dinoprostone—Hypotension—Methylprednisolone—multiple sclerosis	0.000102	0.00192	CcSEcCtD
Dinoprostone—Pain—Prednisolone—multiple sclerosis	0.000102	0.00192	CcSEcCtD
Dinoprostone—Pharyngitis—Methotrexate—multiple sclerosis	0.000101	0.0019	CcSEcCtD
Dinoprostone—Vision blurred—Prednisone—multiple sclerosis	9.96e-05	0.00188	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	9.95e-05	0.00188	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	9.93e-05	0.00187	CcSEcCtD
Dinoprostone—Anaphylactic shock—Betamethasone—multiple sclerosis	9.91e-05	0.00187	CcSEcCtD
Dinoprostone—Anaphylactic shock—Dexamethasone—multiple sclerosis	9.91e-05	0.00187	CcSEcCtD
Dinoprostone—Diarrhoea—Mitoxantrone—multiple sclerosis	9.9e-05	0.00187	CcSEcCtD
Dinoprostone—Paraesthesia—Triamcinolone—multiple sclerosis	9.81e-05	0.00185	CcSEcCtD
Dinoprostone—Paraesthesia—Methylprednisolone—multiple sclerosis	9.78e-05	0.00185	CcSEcCtD
Dinoprostone—Shock—Betamethasone—multiple sclerosis	9.75e-05	0.00184	CcSEcCtD
Dinoprostone—Shock—Dexamethasone—multiple sclerosis	9.75e-05	0.00184	CcSEcCtD
Dinoprostone—Dyspnoea—Triamcinolone—multiple sclerosis	9.74e-05	0.00184	CcSEcCtD
Dinoprostone—Tachycardia—Dexamethasone—multiple sclerosis	9.67e-05	0.00182	CcSEcCtD
Dinoprostone—Tachycardia—Betamethasone—multiple sclerosis	9.67e-05	0.00182	CcSEcCtD
Dinoprostone—Hyperhidrosis—Betamethasone—multiple sclerosis	9.58e-05	0.00181	CcSEcCtD
Dinoprostone—Hyperhidrosis—Dexamethasone—multiple sclerosis	9.58e-05	0.00181	CcSEcCtD
Dinoprostone—Syncope—Prednisone—multiple sclerosis	9.48e-05	0.00179	CcSEcCtD
Dinoprostone—Pain—Triamcinolone—multiple sclerosis	9.34e-05	0.00176	CcSEcCtD
Dinoprostone—Loss of consciousness—Prednisone—multiple sclerosis	9.29e-05	0.00175	CcSEcCtD
Dinoprostone—Hypotension—Dexamethasone—multiple sclerosis	9.26e-05	0.00175	CcSEcCtD
Dinoprostone—Hypotension—Betamethasone—multiple sclerosis	9.26e-05	0.00175	CcSEcCtD
Dinoprostone—Angiopathy—Methotrexate—multiple sclerosis	9.21e-05	0.00174	CcSEcCtD
Dinoprostone—Vomiting—Mitoxantrone—multiple sclerosis	9.2e-05	0.00174	CcSEcCtD
Dinoprostone—Immune system disorder—Methotrexate—multiple sclerosis	9.17e-05	0.00173	CcSEcCtD
Dinoprostone—Hypertension—Prednisone—multiple sclerosis	9.13e-05	0.00172	CcSEcCtD
Dinoprostone—Rash—Mitoxantrone—multiple sclerosis	9.13e-05	0.00172	CcSEcCtD
Dinoprostone—Dermatitis—Mitoxantrone—multiple sclerosis	9.12e-05	0.00172	CcSEcCtD
Dinoprostone—Chills—Methotrexate—multiple sclerosis	9.11e-05	0.00172	CcSEcCtD
Dinoprostone—Headache—Mitoxantrone—multiple sclerosis	9.07e-05	0.00171	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.03e-05	0.0017	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.03e-05	0.0017	CcSEcCtD
Dinoprostone—Arthralgia—Prednisone—multiple sclerosis	9e-05	0.0017	CcSEcCtD
Dinoprostone—Myalgia—Prednisone—multiple sclerosis	9e-05	0.0017	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	8.91e-05	0.00168	CcSEcCtD
Dinoprostone—Paraesthesia—Betamethasone—multiple sclerosis	8.9e-05	0.00168	CcSEcCtD
Dinoprostone—Paraesthesia—Dexamethasone—multiple sclerosis	8.9e-05	0.00168	CcSEcCtD
Dinoprostone—Hypersensitivity—Prednisolone—multiple sclerosis	8.75e-05	0.00165	CcSEcCtD
Dinoprostone—Body temperature increased—Triamcinolone—multiple sclerosis	8.63e-05	0.00163	CcSEcCtD
Dinoprostone—Anaphylactic shock—Prednisone—multiple sclerosis	8.63e-05	0.00163	CcSEcCtD
Dinoprostone—Abdominal pain—Methylprednisolone—multiple sclerosis	8.61e-05	0.00163	CcSEcCtD
Dinoprostone—Nausea—Mitoxantrone—multiple sclerosis	8.6e-05	0.00162	CcSEcCtD
Dinoprostone—Back pain—Methotrexate—multiple sclerosis	8.55e-05	0.00161	CcSEcCtD
Dinoprostone—Shock—Prednisone—multiple sclerosis	8.49e-05	0.0016	CcSEcCtD
Dinoprostone—Pain—Dexamethasone—multiple sclerosis	8.47e-05	0.0016	CcSEcCtD
Dinoprostone—Pain—Betamethasone—multiple sclerosis	8.47e-05	0.0016	CcSEcCtD
Dinoprostone—Tachycardia—Prednisone—multiple sclerosis	8.42e-05	0.00159	CcSEcCtD
Dinoprostone—Hyperhidrosis—Prednisone—multiple sclerosis	8.34e-05	0.00157	CcSEcCtD
Dinoprostone—Vision blurred—Methotrexate—multiple sclerosis	8.33e-05	0.00157	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.1e-05	0.00153	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.1e-05	0.00153	CcSEcCtD
Dinoprostone—Hypersensitivity—Triamcinolone—multiple sclerosis	8.05e-05	0.00152	CcSEcCtD
Dinoprostone—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.03e-05	0.00151	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	7.86e-05	0.00148	CcSEcCtD
Dinoprostone—Dizziness—Prednisolone—multiple sclerosis	7.85e-05	0.00148	CcSEcCtD
Dinoprostone—Asthenia—Triamcinolone—multiple sclerosis	7.83e-05	0.00148	CcSEcCtD
Dinoprostone—Body temperature increased—Dexamethasone—multiple sclerosis	7.83e-05	0.00148	CcSEcCtD
Dinoprostone—Abdominal pain—Betamethasone—multiple sclerosis	7.83e-05	0.00148	CcSEcCtD
Dinoprostone—Body temperature increased—Betamethasone—multiple sclerosis	7.83e-05	0.00148	CcSEcCtD
Dinoprostone—Abdominal pain—Dexamethasone—multiple sclerosis	7.83e-05	0.00148	CcSEcCtD
Dinoprostone—Asthenia—Methylprednisolone—multiple sclerosis	7.82e-05	0.00148	CcSEcCtD
Dinoprostone—Paraesthesia—Prednisone—multiple sclerosis	7.75e-05	0.00146	CcSEcCtD
Dinoprostone—Cough—Methotrexate—multiple sclerosis	7.71e-05	0.00146	CcSEcCtD
Dinoprostone—Myalgia—Methotrexate—multiple sclerosis	7.52e-05	0.00142	CcSEcCtD
Dinoprostone—Arthralgia—Methotrexate—multiple sclerosis	7.52e-05	0.00142	CcSEcCtD
Dinoprostone—Chest pain—Methotrexate—multiple sclerosis	7.52e-05	0.00142	CcSEcCtD
Dinoprostone—Rash—Prednisolone—multiple sclerosis	7.49e-05	0.00141	CcSEcCtD
Dinoprostone—Dermatitis—Prednisolone—multiple sclerosis	7.48e-05	0.00141	CcSEcCtD
Dinoprostone—Diarrhoea—Methylprednisolone—multiple sclerosis	7.45e-05	0.00141	CcSEcCtD
Dinoprostone—Headache—Prednisolone—multiple sclerosis	7.44e-05	0.0014	CcSEcCtD
Dinoprostone—Dizziness—Triamcinolone—multiple sclerosis	7.22e-05	0.00136	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methotrexate—multiple sclerosis	7.21e-05	0.00136	CcSEcCtD
Dinoprostone—Dizziness—Methylprednisolone—multiple sclerosis	7.21e-05	0.00136	CcSEcCtD
Dinoprostone—Asthenia—Dexamethasone—multiple sclerosis	7.11e-05	0.00134	CcSEcCtD
Dinoprostone—Asthenia—Betamethasone—multiple sclerosis	7.11e-05	0.00134	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Prednisone—multiple sclerosis	7.06e-05	0.00133	CcSEcCtD
Dinoprostone—Nausea—Prednisolone—multiple sclerosis	7.05e-05	0.00133	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methotrexate—multiple sclerosis	6.97e-05	0.00132	CcSEcCtD
Dinoprostone—Vomiting—Triamcinolone—multiple sclerosis	6.94e-05	0.00131	CcSEcCtD
Dinoprostone—Vomiting—Methylprednisolone—multiple sclerosis	6.93e-05	0.00131	CcSEcCtD
Dinoprostone—Rash—Triamcinolone—multiple sclerosis	6.89e-05	0.0013	CcSEcCtD
Dinoprostone—Dermatitis—Triamcinolone—multiple sclerosis	6.88e-05	0.0013	CcSEcCtD
Dinoprostone—Rash—Methylprednisolone—multiple sclerosis	6.87e-05	0.0013	CcSEcCtD
Dinoprostone—Dermatitis—Methylprednisolone—multiple sclerosis	6.86e-05	0.0013	CcSEcCtD
Dinoprostone—Headache—Triamcinolone—multiple sclerosis	6.84e-05	0.00129	CcSEcCtD
Dinoprostone—Headache—Methylprednisolone—multiple sclerosis	6.83e-05	0.00129	CcSEcCtD
Dinoprostone—Abdominal pain—Prednisone—multiple sclerosis	6.82e-05	0.00129	CcSEcCtD
Dinoprostone—Body temperature increased—Prednisone—multiple sclerosis	6.82e-05	0.00129	CcSEcCtD
Dinoprostone—Diarrhoea—Betamethasone—multiple sclerosis	6.78e-05	0.00128	CcSEcCtD
Dinoprostone—Diarrhoea—Dexamethasone—multiple sclerosis	6.78e-05	0.00128	CcSEcCtD
Dinoprostone—Hypotension—Methotrexate—multiple sclerosis	6.74e-05	0.00127	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	6.57e-05	0.00124	CcSEcCtD
Dinoprostone—Dizziness—Betamethasone—multiple sclerosis	6.55e-05	0.00124	CcSEcCtD
Dinoprostone—Dizziness—Dexamethasone—multiple sclerosis	6.55e-05	0.00124	CcSEcCtD
Dinoprostone—Nausea—Triamcinolone—multiple sclerosis	6.49e-05	0.00122	CcSEcCtD
Dinoprostone—Paraesthesia—Methotrexate—multiple sclerosis	6.48e-05	0.00122	CcSEcCtD
Dinoprostone—Nausea—Methylprednisolone—multiple sclerosis	6.47e-05	0.00122	CcSEcCtD
Dinoprostone—Dyspnoea—Methotrexate—multiple sclerosis	6.43e-05	0.00121	CcSEcCtD
Dinoprostone—Hypersensitivity—Prednisone—multiple sclerosis	6.36e-05	0.0012	CcSEcCtD
Dinoprostone—Vomiting—Dexamethasone—multiple sclerosis	6.3e-05	0.00119	CcSEcCtD
Dinoprostone—Vomiting—Betamethasone—multiple sclerosis	6.3e-05	0.00119	CcSEcCtD
Dinoprostone—Rash—Dexamethasone—multiple sclerosis	6.25e-05	0.00118	CcSEcCtD
Dinoprostone—Rash—Betamethasone—multiple sclerosis	6.25e-05	0.00118	CcSEcCtD
Dinoprostone—Dermatitis—Betamethasone—multiple sclerosis	6.24e-05	0.00118	CcSEcCtD
Dinoprostone—Dermatitis—Dexamethasone—multiple sclerosis	6.24e-05	0.00118	CcSEcCtD
Dinoprostone—Headache—Dexamethasone—multiple sclerosis	6.21e-05	0.00117	CcSEcCtD
Dinoprostone—Headache—Betamethasone—multiple sclerosis	6.21e-05	0.00117	CcSEcCtD
Dinoprostone—Asthenia—Prednisone—multiple sclerosis	6.19e-05	0.00117	CcSEcCtD
Dinoprostone—Pain—Methotrexate—multiple sclerosis	6.17e-05	0.00116	CcSEcCtD
Dinoprostone—Diarrhoea—Prednisone—multiple sclerosis	5.9e-05	0.00111	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methotrexate—multiple sclerosis	5.9e-05	0.00111	CcSEcCtD
Dinoprostone—Nausea—Dexamethasone—multiple sclerosis	5.89e-05	0.00111	CcSEcCtD
Dinoprostone—Nausea—Betamethasone—multiple sclerosis	5.89e-05	0.00111	CcSEcCtD
Dinoprostone—Dizziness—Prednisone—multiple sclerosis	5.71e-05	0.00108	CcSEcCtD
Dinoprostone—Abdominal pain—Methotrexate—multiple sclerosis	5.7e-05	0.00108	CcSEcCtD
Dinoprostone—Body temperature increased—Methotrexate—multiple sclerosis	5.7e-05	0.00108	CcSEcCtD
Dinoprostone—Vomiting—Prednisone—multiple sclerosis	5.49e-05	0.00104	CcSEcCtD
Dinoprostone—Rash—Prednisone—multiple sclerosis	5.44e-05	0.00103	CcSEcCtD
Dinoprostone—Dermatitis—Prednisone—multiple sclerosis	5.44e-05	0.00103	CcSEcCtD
Dinoprostone—Headache—Prednisone—multiple sclerosis	5.41e-05	0.00102	CcSEcCtD
Dinoprostone—Hypersensitivity—Methotrexate—multiple sclerosis	5.31e-05	0.001	CcSEcCtD
Dinoprostone—Asthenia—Methotrexate—multiple sclerosis	5.17e-05	0.000976	CcSEcCtD
Dinoprostone—Nausea—Prednisone—multiple sclerosis	5.13e-05	0.000967	CcSEcCtD
Dinoprostone—Diarrhoea—Methotrexate—multiple sclerosis	4.93e-05	0.000931	CcSEcCtD
Dinoprostone—Dizziness—Methotrexate—multiple sclerosis	4.77e-05	0.0009	CcSEcCtD
Dinoprostone—Vomiting—Methotrexate—multiple sclerosis	4.59e-05	0.000865	CcSEcCtD
Dinoprostone—Rash—Methotrexate—multiple sclerosis	4.55e-05	0.000858	CcSEcCtD
Dinoprostone—Dermatitis—Methotrexate—multiple sclerosis	4.54e-05	0.000857	CcSEcCtD
Dinoprostone—Headache—Methotrexate—multiple sclerosis	4.52e-05	0.000853	CcSEcCtD
Dinoprostone—Nausea—Methotrexate—multiple sclerosis	4.28e-05	0.000808	CcSEcCtD
Dinoprostone—PTGER1—Signaling Pathways—PTGER4—multiple sclerosis	1.38e-05	0.000148	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTGER4—multiple sclerosis	1.38e-05	0.000148	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GPC5—multiple sclerosis	1.38e-05	0.000147	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CCL5—multiple sclerosis	1.38e-05	0.000147	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—APOE—multiple sclerosis	1.37e-05	0.000147	CbGpPWpGaD
Dinoprostone—SLCO2B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.37e-05	0.000146	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCR3—multiple sclerosis	1.37e-05	0.000146	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PGR—multiple sclerosis	1.36e-05	0.000145	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PGR—multiple sclerosis	1.36e-05	0.000145	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CD28—multiple sclerosis	1.35e-05	0.000144	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—TYK2—multiple sclerosis	1.35e-05	0.000143	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCR3—multiple sclerosis	1.34e-05	0.000143	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCR3—multiple sclerosis	1.34e-05	0.000143	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1.34e-05	0.000142	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.34e-05	0.000142	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—IL2—multiple sclerosis	1.34e-05	0.000142	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCR2—multiple sclerosis	1.33e-05	0.000142	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.32e-05	0.000141	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CD28—multiple sclerosis	1.32e-05	0.000141	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CD28—multiple sclerosis	1.32e-05	0.000141	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—RRM1—multiple sclerosis	1.32e-05	0.00014	CbGpPWpGaD
Dinoprostone—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.31e-05	0.00014	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—BCHE—multiple sclerosis	1.3e-05	0.000139	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—POMC—multiple sclerosis	1.3e-05	0.000139	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCR2—multiple sclerosis	1.3e-05	0.000139	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCR2—multiple sclerosis	1.3e-05	0.000139	CbGpPWpGaD
Dinoprostone—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.3e-05	0.000138	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CD86—multiple sclerosis	1.29e-05	0.000138	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.29e-05	0.000137	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GPC5—multiple sclerosis	1.28e-05	0.000137	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SPP1—multiple sclerosis	1.27e-05	0.000136	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCL5—multiple sclerosis	1.27e-05	0.000136	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.26e-05	0.000135	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—POMC—multiple sclerosis	1.25e-05	0.000133	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—RRM1—multiple sclerosis	1.25e-05	0.000133	CbGpPWpGaD
Dinoprostone—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.24e-05	0.000133	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CD80—multiple sclerosis	1.24e-05	0.000132	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CCR5—multiple sclerosis	1.24e-05	0.000132	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—IL2—multiple sclerosis	1.23e-05	0.000131	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CNR1—multiple sclerosis	1.23e-05	0.000131	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL2RA—multiple sclerosis	1.22e-05	0.00013	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—POMC—multiple sclerosis	1.22e-05	0.00013	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—POMC—multiple sclerosis	1.22e-05	0.00013	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL2—multiple sclerosis	1.21e-05	0.000129	CbGpPWpGaD
Dinoprostone—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.21e-05	0.000129	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.21e-05	0.000129	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CNR1—multiple sclerosis	1.2e-05	0.000128	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CNR1—multiple sclerosis	1.2e-05	0.000128	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—ALB—multiple sclerosis	1.19e-05	0.000126	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—POMC—multiple sclerosis	1.18e-05	0.000126	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SPP1—multiple sclerosis	1.18e-05	0.000125	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CD86—multiple sclerosis	1.16e-05	0.000124	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CCL2—multiple sclerosis	1.15e-05	0.000123	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCR5—multiple sclerosis	1.14e-05	0.000122	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000122	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—RRM1—multiple sclerosis	1.14e-05	0.000122	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—POMC—multiple sclerosis	1.13e-05	0.000121	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—MAPK1—multiple sclerosis	1.13e-05	0.000121	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.13e-05	0.000121	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—APOE—multiple sclerosis	1.13e-05	0.00012	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL2RA—multiple sclerosis	1.13e-05	0.00012	CbGpPWpGaD
Dinoprostone—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.13e-05	0.00012	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL2—multiple sclerosis	1.12e-05	0.000119	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TGFB1—multiple sclerosis	1.11e-05	0.000119	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—POMC—multiple sclerosis	1.11e-05	0.000118	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—POMC—multiple sclerosis	1.11e-05	0.000118	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—CCL2—multiple sclerosis	1.11e-05	0.000118	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL10—multiple sclerosis	1.1e-05	0.000118	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—MAPK1—multiple sclerosis	1.09e-05	0.000116	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—CCL2—multiple sclerosis	1.08e-05	0.000116	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—CCL2—multiple sclerosis	1.08e-05	0.000116	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL10—multiple sclerosis	1.08e-05	0.000115	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL10—multiple sclerosis	1.08e-05	0.000115	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—RRM1—multiple sclerosis	1.06e-05	0.000113	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—ALB—multiple sclerosis	1.05e-05	0.000112	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TYK2—multiple sclerosis	1.05e-05	0.000112	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—APOE—multiple sclerosis	1.04e-05	0.000111	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CCR5—multiple sclerosis	1.03e-05	0.00011	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.02e-05	0.000109	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CD80—multiple sclerosis	1.02e-05	0.000109	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—TYK2—multiple sclerosis	1.01e-05	0.000107	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HLA-A—multiple sclerosis	1e-05	0.000107	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	9.93e-06	0.000106	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—TYK2—multiple sclerosis	9.85e-06	0.000105	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—TYK2—multiple sclerosis	9.85e-06	0.000105	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.7e-06	0.000104	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—POMC—multiple sclerosis	9.69e-06	0.000103	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.66e-06	0.000103	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CD86—multiple sclerosis	9.65e-06	0.000103	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCL5—multiple sclerosis	9.5e-06	0.000101	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CCL2—multiple sclerosis	9.48e-06	0.000101	CbGpPWpGaD
Dinoprostone—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.47e-06	0.000101	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CD86—multiple sclerosis	9.44e-06	0.000101	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CD86—multiple sclerosis	9.44e-06	0.000101	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CD80—multiple sclerosis	9.41e-06	0.0001	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—APOE—multiple sclerosis	9.36e-06	9.98e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SRM—multiple sclerosis	9.32e-06	9.94e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCL5—multiple sclerosis	9.3e-06	9.92e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCL5—multiple sclerosis	9.3e-06	9.92e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—MAPK1—multiple sclerosis	9.28e-06	9.9e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	9.25e-06	9.87e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—IL2—multiple sclerosis	9.22e-06	9.83e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.08e-06	9.69e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—IL2—multiple sclerosis	9.02e-06	9.62e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—IL2—multiple sclerosis	9.02e-06	9.62e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—POMC—multiple sclerosis	8.94e-06	9.54e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.85e-06	9.44e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SPP1—multiple sclerosis	8.8e-06	9.38e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.77e-06	9.36e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCL2—multiple sclerosis	8.75e-06	9.34e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL2—multiple sclerosis	8.72e-06	9.31e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL6—multiple sclerosis	8.68e-06	9.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	8.64e-06	9.21e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SPP1—multiple sclerosis	8.61e-06	9.19e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SPP1—multiple sclerosis	8.61e-06	9.19e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TYK2—multiple sclerosis	8.61e-06	9.19e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—MAPK1—multiple sclerosis	8.56e-06	9.13e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCR5—multiple sclerosis	8.56e-06	9.13e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—IL2—multiple sclerosis	8.51e-06	9.08e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CD80—multiple sclerosis	8.46e-06	9.03e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2RA—multiple sclerosis	8.43e-06	9e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.41e-06	8.97e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCR5—multiple sclerosis	8.38e-06	8.94e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCR5—multiple sclerosis	8.38e-06	8.94e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL2—multiple sclerosis	8.37e-06	8.93e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—BCHE—multiple sclerosis	8.36e-06	8.92e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.3e-06	8.85e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MMP9—multiple sclerosis	8.26e-06	8.81e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2RA—multiple sclerosis	8.25e-06	8.81e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2RA—multiple sclerosis	8.25e-06	8.81e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL2—multiple sclerosis	8.19e-06	8.74e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL2—multiple sclerosis	8.19e-06	8.74e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8e-06	8.53e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TYK2—multiple sclerosis	7.95e-06	8.48e-05	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.91e-06	8.44e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—APOE—multiple sclerosis	7.84e-06	8.36e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—APOE—multiple sclerosis	7.78e-06	8.3e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—APOE—multiple sclerosis	7.62e-06	8.13e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—APOE—multiple sclerosis	7.62e-06	8.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	7.61e-06	8.11e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.57e-06	8.07e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—BCHE—multiple sclerosis	7.56e-06	8.06e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—STAT3—multiple sclerosis	7.34e-06	7.83e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.19e-06	7.67e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL2—multiple sclerosis	7.16e-06	7.64e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—BCHE—multiple sclerosis	7.15e-06	7.63e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TYK2—multiple sclerosis	7.14e-06	7.62e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL6—multiple sclerosis	7.13e-06	7.6e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	7.09e-06	7.56e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CD80—multiple sclerosis	7.04e-06	7.51e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CD80—multiple sclerosis	6.89e-06	7.35e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CD80—multiple sclerosis	6.89e-06	7.35e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—APOE—multiple sclerosis	6.86e-06	7.32e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MYC—multiple sclerosis	6.82e-06	7.28e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFB1—multiple sclerosis	6.81e-06	7.26e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MMP9—multiple sclerosis	6.78e-06	7.23e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—POMC—multiple sclerosis	6.73e-06	7.18e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—POMC—multiple sclerosis	6.69e-06	7.13e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MAPK1—multiple sclerosis	6.67e-06	7.12e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TGFB1—multiple sclerosis	6.64e-06	7.08e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL2—multiple sclerosis	6.61e-06	7.05e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.59e-06	7.03e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—multiple sclerosis	6.58e-06	7.02e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	6.57e-06	7e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	6.57e-06	7e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—BCHE—multiple sclerosis	6.55e-06	6.99e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—POMC—multiple sclerosis	6.55e-06	6.98e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—POMC—multiple sclerosis	6.55e-06	6.98e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCL2—multiple sclerosis	6.54e-06	6.98e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—MAPK1—multiple sclerosis	6.51e-06	6.94e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CD4—multiple sclerosis	6.46e-06	6.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.42e-06	6.85e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCL2—multiple sclerosis	6.4e-06	6.83e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCL2—multiple sclerosis	6.4e-06	6.83e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—MAPK1—multiple sclerosis	6.4e-06	6.83e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—MAPK1—multiple sclerosis	6.27e-06	6.69e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—MAPK1—multiple sclerosis	6.27e-06	6.69e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MMP9—multiple sclerosis	6.26e-06	6.68e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.14e-06	6.55e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ALB—multiple sclerosis	6.14e-06	6.55e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—BCHE—multiple sclerosis	6.11e-06	6.52e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—STAT3—multiple sclerosis	6.03e-06	6.43e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPC5—multiple sclerosis	6.01e-06	6.41e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TYK2—multiple sclerosis	5.94e-06	6.34e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—POMC—multiple sclerosis	5.9e-06	6.29e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TYK2—multiple sclerosis	5.82e-06	6.2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TYK2—multiple sclerosis	5.82e-06	6.2e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—multiple sclerosis	5.6e-06	5.98e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—multiple sclerosis	5.59e-06	5.96e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—STAT3—multiple sclerosis	5.56e-06	5.94e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAPK1—multiple sclerosis	5.48e-06	5.85e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ALB—multiple sclerosis	5.38e-06	5.73e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—multiple sclerosis	5.17e-06	5.52e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—multiple sclerosis	5.16e-06	5.5e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—multiple sclerosis	5.13e-06	5.47e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK1—multiple sclerosis	5.06e-06	5.4e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOE—multiple sclerosis	5.03e-06	5.37e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—multiple sclerosis	5e-06	5.33e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—RRM1—multiple sclerosis	4.98e-06	5.31e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2—multiple sclerosis	4.94e-06	5.27e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—multiple sclerosis	4.92e-06	5.25e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2—multiple sclerosis	4.84e-06	5.16e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2—multiple sclerosis	4.84e-06	5.16e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—multiple sclerosis	4.82e-06	5.14e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—multiple sclerosis	4.82e-06	5.14e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—multiple sclerosis	4.68e-06	4.99e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—multiple sclerosis	4.65e-06	4.96e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—multiple sclerosis	4.64e-06	4.95e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—multiple sclerosis	4.58e-06	4.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—multiple sclerosis	4.58e-06	4.89e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOE—multiple sclerosis	4.55e-06	4.85e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK1—multiple sclerosis	4.55e-06	4.85e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—POMC—multiple sclerosis	4.32e-06	4.61e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOE—multiple sclerosis	4.3e-06	4.59e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—multiple sclerosis	4.21e-06	4.49e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—multiple sclerosis	4.16e-06	4.44e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—multiple sclerosis	4.07e-06	4.34e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—multiple sclerosis	4.07e-06	4.34e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOE—multiple sclerosis	3.94e-06	4.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—multiple sclerosis	3.94e-06	4.2e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—POMC—multiple sclerosis	3.91e-06	4.17e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—multiple sclerosis	3.89e-06	4.15e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—multiple sclerosis	3.87e-06	4.12e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.86e-06	4.12e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—multiple sclerosis	3.86e-06	4.11e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—multiple sclerosis	3.78e-06	4.04e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—multiple sclerosis	3.78e-06	4.04e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK1—multiple sclerosis	3.78e-06	4.03e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—multiple sclerosis	3.77e-06	4.03e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—multiple sclerosis	3.77e-06	4.03e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK1—multiple sclerosis	3.7e-06	3.95e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK1—multiple sclerosis	3.7e-06	3.95e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—POMC—multiple sclerosis	3.7e-06	3.94e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOE—multiple sclerosis	3.67e-06	3.92e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—multiple sclerosis	3.56e-06	3.8e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—multiple sclerosis	3.49e-06	3.73e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—POMC—multiple sclerosis	3.39e-06	3.61e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—multiple sclerosis	3.37e-06	3.59e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.32e-06	3.54e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—POMC—multiple sclerosis	3.16e-06	3.37e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—multiple sclerosis	3.09e-06	3.29e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.02e-06	3.23e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—multiple sclerosis	2.91e-06	3.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—multiple sclerosis	2.88e-06	3.07e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.86e-06	3.05e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—multiple sclerosis	2.84e-06	3.03e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—multiple sclerosis	2.84e-06	3.03e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOE—multiple sclerosis	1.72e-06	1.83e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—POMC—multiple sclerosis	1.48e-06	1.58e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—multiple sclerosis	1.35e-06	1.44e-05	CbGpPWpGaD
